TrydingDay · public market coverage
Coverage
A dated index of the public market coverage record.
Latest coverage
The five most recent episodes
XTR.L · Xtract Resources Plc
XTR.L gained 8.00% with 2.54x its three-month average volume in the captured quote. Relative strength and the reviewed multi-timeframe structure were constructive, while no attributable ticker-news record was captured.
XTR.L closes its fifteen-session observation at -7.41% from the 1.35 reference. The original Early Try had a strong impulse and constructive multi-timeframe structure, but the later repairs did not become durable. The fresh final market-data capture was 1.25 with 0.72x participation, RSI 66.23 and a rising EMA structure of 1.22 > 1.15 > 1.11. Episode-specific X evidence and current 52-week position data are unavailable. Tracking ends.
CATCH · Catch
Broad conditions were mildly supportive: oil eased on a reported diplomatic opening and index futures edged higher, while healthcare received focus. That backdrop helped several names print gains, but the comparison split between event-driven gaps with fading intraday control and quieter charts with insufficiently specific catalysts. The result is a market with opportunity signals but no single candidate whose explanation, reaction, participation, and near-term risk line up cleanly.
F · Ford Motor Company
Early Try: F. F ranks first among fourteen valid prepared coiled cases for an early public review, but the thesis remains conditional on confirmation and disciplined invalidation. A United States research input is stale by one Canary day; this lowers confidence but does not veto the comparison. This is a prospective review and not an execution instruction.
F's 15-session tracking closes at -1.17% from the $14.58 reference. The fresh regular capture was $14.41, up 3.00% on the session and 2.88% from the prior close on 0.69x participation; the extended quote was $14.42, up 0.07%. The original Early Try ranked F first among fourteen cases but required confirmation. The path reached +3.29% before the recovery failed. RSI 45.09 and EMA 14.34 > 14.33 > 14.12 remain available; 52-week position data and episode-specific X evidence do not. Tracking ends.
SNOW · Snowflake Inc.
SNOW is selected as an Early Try from the prepared confirmed-break set. The positive observed move gives it the clearest early signal, while quiet participation and conflicting information keep the thesis explicitly current and dependent on the next observable check.
SNOW's 15-session tracking closes with a complete canonical outcome of +9.14% from the $294.375 reference. The final regular-session capture was $321.29, down 1.14% on the session and 1.27% from the prior regular close; the extended quote was $320.64, down 0.20% after hours. The original Early Try thesis identified the clearest positive confirmed break, while already warning that participation was quiet and the information picture was conflicting. The path later reached a 16.16% maximum favorable excursion, but the final capture still showed high RSI, 0.44x participation and pressure after a pullback. The directional result paid, but the evidence never earned a durable company-specific confirmation; tracking now ends.
MSFT · Microsoft Corporation
The panel selects MSFT as Try of the Day after comparing the full candidate set. Its strong move, exceptional participation, relative strength and visible range expansion outweigh the alternatives, while the thesis remains conditional on the breakout holding with continued evidence.
MSFT closes session-15 tracking at a canonical +5.65% from the $455.40 reference. The fresh regular capture was $481.15, down 0.47% on the session and 0.71% from the prior close; the extended quote was $481.01, down 0.03%. The original Try of the Day thesis rested on strong participation, relative strength and range expansion, conditional on breakout retention. The path reached a 12.81% maximum favorable excursion before momentum faded. Final evidence shows the breakout still visible but no renewed demand, while current RSI and EMA are unavailable. The measured gain is complete; public tracking ends.
Earlier coverage
The archive continues
CAKE · The Cheesecake Factory Incorporated
Public Tryding Review: CAKE is the committee's selection after comparative review. Its specific revenue catalyst, positive relative performance, above-VWAP action and coherent multi-horizon structure outweighed the stronger raw momentum of GRMN, the earnings move in LAD and the transaction-driven repricing in CBZ. The thesis remains conditional because CAKE is extended, with RSI 82.31, a 6.38% gap and elevated short-interest risk.
CAKE's 15-session tracking closes with a complete canonical outcome of +4.82% from the $99.25 public reference. The final regular-session capture was $105.82, down 0.51% on the session and 1.14% from the prior regular close; the extended quote was $106.12, up 0.28% after hours. The original thesis paired a specific revenue catalyst with relative strength, above-average price structure and a coherent multi-horizon trend, while extension and short-interest risk were explicit from the start. CAKE reached a much stronger interim gain before giving back ground and finishing positive but well below its best observed level. The result is recorded and the observation ends; the catalyst remains context, not proof of durable follow-through.
RCL · Royal Caribbean Cruises Ltd.
RCL is the Try of the Day: a primary SEC 8-K, price above VWAP at 314.61, an up intraday trend, 93.6 percent range position and 1.99x time RVOL outweigh weaker alternatives. The thesis remains current because RSI 73.65, 2.26 ATR extension and lower sales guidance leave continuation exposed to event digestion.
RCL's 15-session tracking closes with a complete canonical outcome of -7.16% from the $320.15 reference. The fresh premarket capture is $300.00, with the provider marking the extended move at -0.04% and 0.40x relative volume; RSI and EMA data are unavailable in this capture. The original Try of the Day joined a primary SEC 8-K, above-VWAP structure and strong participation, while lower sales guidance and extension were already live objections. The record later moved through attempted repair but repeatedly lacked renewed demand and ended with a -8.05% maximum adverse excursion against a 3.36% favorable excursion. The issuer event remains context, not a rescue; the measured loss ends the public observation.
CATCH · Catch
Caught: No Try. Ten candidates had usable trajectories, but none established a clear comparative edge. OVBC held above VWAP on weak participation, while IDYA and SRI lacked the coverage required for a public selection.
WKC · World Kinect Corporation
WKC is selected as Raw Try. Its trajectory improves across the sealed observations and runtime public research identifies an official second-quarter operating mechanism. DLR remains the strongest discarded alternative because its initial move fades; the decision remains conditional because the sealed information lane is insufficient_coverage and fuel-volatility risk remains material.
WKC's 15-session tracking closes with a complete canonical outcome of -10.04% from the $40.14 reference. The final regular-session capture was $36.11, down 2.72% on the session and 2.64% from the prior regular close; the extended quote was $36.11, up 0.03% after hours. The original Raw Try thesis joined an improving observed trajectory with an official second-quarter operating mechanism tied to fuel volatility. The record later lost the published confirmation area, showed repeated distribution and ended below the reference despite a still-rising EMA structure. The result is recorded and the observation ends; the issuer mechanism remains a plausible explanation for the original move, not a reason to keep the thesis open.
Base $40.14 · Close $36.11
LMT · LMT
LMT – Try of the Day. The Q2 2026 results release is paired with a complete 13-point session trajectory ending at 569.76 and +10.77%, with observed volume rising from 1.48M to 2.49M. Confidence is moderate because the source is issuer-only and the move dipped intraday.
LMT's 15-session tracking closes with a canonical final outcome of +4.96% from the $569.76 reference. The final regular-session capture was $598.01, down 1.44% on the day and 1.88% from the prior regular close; the extended quote was $598.83, up 0.14% after hours. The original thesis tied the move to Lockheed Martin's Q2 2026 results release and a complete positive provider trajectory. The record shows the thesis survived an early pullback and produced a positive terminal result, but later gains were repeatedly exposed to elevated RSI and uneven participation. The observation now ends: the result is recorded, while the issuer-only mechanism remains a plausible explanation rather than independent proof.
Base $570.38 · Close $598.01
ARWR · Arrowhead Pharmaceuticals
A publicly available report published at 18:25 UTC and indexed at 19:20 UTC described strong efficacy in cutting blood fat. That time-stamped item was the clearest public development aligned with ARWR's move.
ARWR reaches the end of its 15-session observation window with the canonical session-15 outcome still pending. The fresh after-market capture is $87.25, or -3.59% from the $90.50 reference, versus $89.24 at the prior regular close; the extended quote is $87.30, up 0.06% after hours. The original thesis linked the move to a public report about Arrowhead drug efficacy. The record shows repeated repair attempts, but light participation and weak follow-through left the thesis unconfirmed. Tracking now ends: this closure does not invent a session-15 return, and the pending canonical outcome remains an explicit limitation.
Base $90.50 · Close $87.25
CATCH · Catch
The tape offered activity, not a complete case: AGIO carried a real but adverse catalyst and unreliable quote conditions; CLBT lacked a fresh mechanism; BVC had only its initial scan observation. UPS remains a separate Coiled watch until its information record is verified. The desk kept the daily slate clear rather than convert isolated signals into a selection.
AMC · AMC
AMC remains a Raw Try. The session kept the same conditional thesis: a dated Reuters report supplied a plausible catalyst and the tape held above VWAP, but cooling relative volume and pending primary confirmation leave follow-through unresolved.
AMC closes its 15-session tracking window with a complete canonical outcome of +0.83% from the $2.40 entry. The fresh after-market capture is $2.43, or +1.25% versus the reference, with 0.38x volume and a 2.62 > 2.44 > 2.17 EMA stack. The original Raw Try thesis correctly identified a dated earnings explanation and an observable price response, but neither durable follow-through nor primary confirmation was established. The episode is closed as a conditional thesis that is no longer followed.
Base $2.40 · Close $2.42
TRVI · Trevi Therapeutics, Inc.
TRVI led the day scan after a 9.01% gain on 2.41x relative volume, with a bullish EMA stack and exceptional volume percentile. The later confirmation held above VWAP, but no independent trusted catalyst was identified; the public conclusion is therefore a conditional Raw Try rather than a Try of the Day.
TRVI closes its 15-session tracking window at $18.51 against the $18.96 scanner reference, a complete -2.37% outcome; the fresh after-market quote is also $18.51. The original Raw Try thesis correctly identified a constructive tape above VWAP, but it also named decelerating participation and the absence of a verified catalyst as decisive caveats. The subsequent recovery attempts never produced durable follow-through, so the Mesa closes the episode as an unresolved conditional thesis rather than a confirmed continuation, and it is no longer followed.
Base $18.96 · Close $18.51
CATCH · Catch
The panel rejects a public selected case today. LCID's momentum is real, but the solvency shock, contradictory headlines, extreme volatility and missing base confirmation outweigh the mechanical score; the session is therefore classified as Catch: No Try.
CATCH · Catch
The scan produced no qualifying long selected case today. CLSK had a strong catalyst and relative strength, but its 4.7 score was weakened by a bearish EMA stack, trading below VWAP during a gap-fill session, and unusually wide quoted spreads. TSEM scored 1.8 and also lacked a confirmed long structure. The panel requires cleaner price structure, VWAP recovery, and a defined risk map before treating either setup as publishable momentum.
VOD · Vodafone Group Public Limited Company
The scan is reacting to the reported Vega acquisition of a 16.2% Vodafone stake, alongside a +5.47% move, bullish news tone, strong ATR participation and relative strength against the index.
Base $15.53 · Close $15.61
CATCH · Catch
Vodafone delivered a strong, catalyst-driven gap on exceptional attention after Xavier Niel's investment became public, but the intraday bid lost control below VWAP and the broader moving-average structure remains bearish. With no defined long entry, stop, or target in the scan, the panel treats the move as a watchlist event rather than a disciplined fresh setup. A valid follow-through would need to reclaim and hold above VWAP while rebuilding the 9/21/50-day trend structure.
PENG · Penguin Solutions, Inc.
PENG stood out after a +12.78% session on 1.54x average volume, with fresh coverage around stronger results, raised expectations and expanding AI infrastructure demand. The scan also showed bullish sentiment, exceptional volume percentile, sector support and price action near a 52-week high.
Base $88.68 · Close $51.43
KC · Kingsoft Cloud Holdings Limited
KC led today's scan with a +12.34% move on 2.17x volume. The tape is broad enough to matter: bullish sentiment, strong relative strength versus QQQ and a clean gap-hold profile.
Base $10.61 · Close $9.90
TRVI · Trevi Therapeutics, Inc.
No confirmed news catalyst today. TRVI was removed from the Russell 3000E Growth and Microcap indices in late June, which triggered forced index-fund selling. Today's +9.69% idiosyncratic move while QQQ falls -1.76% is consistent with a post-reconstitution relief rally as that selling pressure dissipates. Technical setup is strong: EMA stack fully aligned (9>21>50), Healthcare sector green (+1.68%), intraday momentum confirmed (above VWAP, 79th percentile of the day's range, relative volume 3.9x). The absence of a confirmed fundamental catalyst is the primary risk.
TRVI closes its 15-session tracking window at $18.43 against the $19.72 reference, a complete -6.54% outcome; the fresh after-market quote is $18.51. The original post-reconstitution relief thesis had a technically strong start but no confirmed catalyst, and the subsequent fade, brief session-5 rebound, and failure to build the required higher low and tighter base left the recovery case unconfirmed. The Mesa's terminal judgment is that this episode is closed and no longer followed; one episode cannot establish a general edge.
Base $19.72 · Close $18.43
IQMX · IQM Quantum Computers Oyj
IQMX gained +8.79% on July 6 on volume 3.92× the 3-month average, driven by a Seeking Alpha article titled “Tailwinds Still Building” highlighting continued institutional interest in quantum computing infrastructure. The broader technology sector (XLK +2.3%) provided macro tailwind, and IQMX outperformed QQQ by +7.09 percentage points on the session. EMAs are cleanly stacked bullish (EMA9 12.11 > EMA21 11.50 > EMA50 11.18) and the stock trades at 93.9% of its 52-week high. RSI at 82.7 is extended — this is a setup that already moved; the scanner flagged it for momentum tracking, not as a bottom entry.
Base $14.20 · Close $10.80
PLBL · Polibeli Group Ltd
PLBL topped the board with a score of 6.8 on a +12.9% move, holding above VWAP (range position 0.92) with RVOL 4.4x and idiosyncratic relative strength (+13.8% versus a QQQ that was down 0.9%). But the catalyst is weak: only an [EFFECT] SEC filing with neutral sentiment (0.01), and the consumer-cyclical sector (XLY) was red on the day. This is the same micro-float that ran +49% in June, so the move is momentum and short-float mechanics rather than a fresh fundamental catalyst.
Base $9.82 · Close $7.55
DLO · DLocal Limited
DLO rose +11.3% on volume 3.5x its average, the 98th percentile of its own 3-month distribution (exceptional for the stock itself). The move is idiosyncratic: QQQ fell -1.2% today while DLO diverged with +11.5% of excess over the index. Confluence of signals: EMA9>EMA21>EMA50 bullish, a strong move relative to its ATR, recent insider buying (a director bought 20,000 shares in June) and mostly Buy analyst coverage (target 17.35). There is no clean headline catalyst today; the push is technical and positioning-driven, not news.
Base $14.49 · Close $14.08
HSAI · Hesai Group
Two fresh catalysts on June 29: a new automaker contract win (Somewhat-Bullish, 0.31) and the Thoro.ai AMR partnership using the JT128 sensor (Bullish, 0.74). The AGM on June 26 approved an 8-for-1 share split. Volume at 2.61x the 3-month average. Intraday signal is the strongest of the session: price above VWAP ($17.97), top 88% of day range, RVOL 4.26x, hourly trend up. Daily EMA is not yet stacked bullish (EMA9 16.57 still below EMA21 17.59) — this is a recovery in progress, not a confirmed breakout. Score 6.3.
Base $18.44 · Close $14.88